NOCIL Limited Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected

Shareholders might have noticed that NOCIL Limited (NSE:NOCIL) filed its quarterly result this time last week. The early response was not positive, with shares down 2.9% to ₹174 in the past week. Revenues came in 5.5% below expectations, at ₹3.4b. Statutory earnings per share were relatively better off, with a per-share profit of ₹6.15 being roughly in line with analyst estimates. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

Taking into account the latest results, the current consensus from NOCIL's six analysts is for revenues of ₹14.4b in 2026. This would reflect a modest 6.5% increase on its revenue over the past 12 months. Statutory earnings per share are predicted to accumulate 8.6% to ₹6.05. Before this earnings report, the analysts had been forecasting revenues of ₹15.0b and earnings per share (EPS) of ₹8.90 in 2026. From this we can that sentiment has definitely become more bearish after the latest results, leading to lower revenue forecasts and a pretty serious reduction to earnings per share estimates.

Check out our latest analysis for NOCIL

The analysts made no major changes to their price target of ₹208, suggesting the downgrades are not expected to have a long-term impact on NOCIL's valuation. It could also be instructive to look at the range of analyst estimates, to evaluate how different the outlier opinions are from the mean. There are some variant perceptions on NOCIL, with the most bullish analyst valuing it at ₹319 and the most bearish at ₹126 per share. This is a fairly broad spread of estimates, suggesting that analysts are forecasting a wide range of possible outcomes for the business.

Another way we can view these estimates is in the context of the bigger picture, such as how the forecasts stack up against past performance, and whether forecasts are more or less bullish relative to other companies in the industry. We can infer from the latest estimates that forecasts expect a continuation of NOCIL'shistorical trends, as the 8.7% annualised revenue growth to the end of 2026 is roughly in line with the 8.5% annual growth over the past five years. Compare this with the broader industry (in aggregate), which analyst estimates suggest will see revenues grow 13% annually. So it's pretty clear that NOCIL is expected to grow slower than similar companies in the same industry.

The Bottom Line

The biggest concern is that the analysts reduced their earnings per share estimates, suggesting business headwinds could lay ahead for NOCIL. Unfortunately, they also downgraded their revenue estimates, and our data indicates underperformance compared to the wider industry. Even so, earnings per share are more important to the intrinsic value of the business. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

With that in mind, we wouldn't be too quick to come to a conclusion on NOCIL. Long-term earnings power is much more important than next year's profits. At Simply Wall St, we have a full range of analyst estimates for NOCIL going out to 2028, and you can see them free on our platform here..

You still need to take note of risks, for example - NOCIL has 1 warning sign we think you should be aware of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.